2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 3.153 | 5.868 | 7.046 | 10.838 | 35.156 | 885 | 21.314 | 7.660 | 32.390 | 69.650 |
Total Income - EUR | 3.744 | 5.868 | 7.046 | 10.838 | 35.156 | 890 | 21.314 | 7.664 | 32.390 | 69.650 |
Total Expenses - EUR | 3.638 | 4.794 | 6.574 | 5.696 | 21.994 | 8.569 | 25.926 | 7.395 | 11.079 | 13.108 |
Gross Profit/Loss - EUR | 106 | 1.074 | 472 | 5.142 | 13.162 | -7.679 | -4.612 | 268 | 21.310 | 56.542 |
Net Profit/Loss - EUR | 89 | 898 | 282 | 4.817 | 12.810 | -7.688 | -4.825 | 38 | 20.987 | 55.846 |
Employees | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Omicron Plus Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 180 | 0 | 0 | 0 | 15.945 | 16.010 | 15.707 | 15.358 | 16.177 | 20.127 |
Current Assets | 24.698 | 25.769 | 28.762 | 44.585 | 43.512 | 26.607 | 30.902 | 29.487 | 45.970 | 37.343 |
Inventories | 15.060 | 16.341 | 16.174 | 23.387 | 17.237 | 17.627 | 12.742 | 21.772 | 21.840 | 21.773 |
Receivables | 2 | 4.938 | 10.100 | 8.272 | 26.261 | 8.157 | 17.580 | 7.703 | 4.056 | 6.873 |
Cash | 9.635 | 4.490 | 2.488 | 12.926 | 14 | 823 | 580 | 12 | 20.075 | 8.697 |
Shareholders Funds | 20.503 | 21.572 | 21.634 | 26.084 | 38.416 | 29.986 | 24.592 | 24.085 | 45.147 | 55.896 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 44 | 43 | 42 | 43 | 42 |
Debts | 4.374 | 4.197 | 7.128 | 18.500 | 21.041 | 12.632 | 22.016 | 20.760 | 17.001 | 1.574 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "2825 - 2825" | |||||||||
CAEN Financial Year |
7410
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Omicron Plus Srl